7th Oncolytic Virotherapy Summit 2022
Evvnt Promotion / evvnt
Archive
06.12.2022 - 08.12.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am to 4:00 pm
Conference themes
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
Scientific Society
Hanson Wade
Hanson Wade
Notes
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
Enquiries and Registration:
https://go.evvnt.com/1259262-2?pid=4832
Ms. Stephanie Nketia
Health Services, Public Health
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
